John R Fischer

Lightyear has realized several investments in mental health, including Therapy Brands, which it sold to KKR for $1.25bn in 2021.

'The only thing a big company can do to address rising healthcare costs is to prevent the health outcomes driving most of those expenses,' Consello Capital's Peter Morrow said.

Launched in 2022, Cypress Ridge targets payor services, healthcare providers, health IT and pharmaceutical services companies with enterprise values between $20m and $100m.

'As competition in the private equity space intensifies, rebranding helps Avista stand out as a specialist in healthcare,' managing director Amanda Heravi told PE Hub.

Apax, Duke Street and NMS Capital are among several PE firms investing in radiology practices and imaging equipment manufacturers.

SK Capital, Nordic Capital Partners and KKR are among the many PE firms looking at specialty pharma companies developing rare disease treatments.

'Despite the slowdown in PE-backed healthcare services transactions in 2023, in part due to the regulatory environment, there is still value to be unlocked.'

Avista will retain a significant equity stake and jointly manage Cosette’s growth alongside Hamilton Lane, PE Hub has learned.

Michael Fosnaugh discusses the Model N deal and Vista's strategy.

BPOC, Archimed and OMERS are among the PE firms buying and selling companies that sell over-the-counter pharmacy items online.